This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Rite Aid Reports Same Store Sales For February

Rite Aid Corporation (NYSE: RAD) today announced sales results for February.

Monthly SalesFor the five weeks ended March 2, 2013, same store sales decreased 3.6 percent over the prior-year period. February front-end same store sales decreased 1.3 percent while February front-end same store sales attributable to flu-related over-the-counter products were flat. Pharmacy same store sales, which included an approximate 695 basis points negative impact from new generic introductions, decreased 4.7 percent. Prescription count at comparable stores increased 0.3 percent over the prior-year period. This number includes a decrease of 0.1 percent attributable to flu-related prescriptions and flu shots.

Total drugstore sales for the five-week period decreased 3.7 percent to $2.457 billion compared to $2.551 billion for the same period last year. Prescription sales accounted for 67.7 percent of drugstore sales, and third party prescription sales represented 96.9 percent of pharmacy sales.

Quarterly SalesSame store sales for the 13-week period ended March 2, 2013 decreased 2.0 percent over the prior-year period. Front-end same store sales increased 0.3 percent while pharmacy same store sales decreased 3.1 percent. Prescription count at comparable stores increased 3.0 percent over the prior-year period.

Total drugstore sales for the 13-week period decreased 2.4 percent with sales of $6.425 billion compared to $6.585 billion for the same period last year. Prescription sales represented 66.5 percent of total drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.

Year End SalesSame store sales for the 52-week period ended March 2, 2013 decreased 0.3 percent over the prior-year period. Front-end same store sales increased 1.4 percent while pharmacy same store sales decreased 1.0 percent. Prescription count at comparable stores increased 3.4 percent over the prior-year period.

Total drugstore sales for the 52 weeks ended March 2, 2013 decreased 0.9 percent with sales of $25.284 billion compared to $25.504 billion for the same period last year. Prescription sales represented 67.6 percent of total drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs